AbbVie Inc. vs Novartis AG
AbbVie Inc. is worth $464.575B, 1.6× the $299.439B market cap of Novartis AG. Updated daily.
| Metric | AbbVie Inc.ABBV  | Novartis AGNVS  |
|---|---|---|
| Market cap | $464.575B | $299.439B |
| Global rank | #1 | #2 |
| Share price | $262.90 | $157.54 |
| Change | +5.12% | +1.90% |
| Revenue | $61.160B | $56.674B |
| Net income | $4.226B | $13.984B |
| Country | United States | Switzerland |
| Sector | Healthcare | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is AbbVie Inc. bigger than Novartis AG?
- AbbVie Inc. has a market cap of $464.575B against $299.439B for Novartis AG, making it 1.6 times as valuable.
- Which company earns more, ABBV or NVS?
- AbbVie Inc. reported net income of $4.226B and Novartis AG reported $13.984B in their most recent annual periods.